Edition:
United Kingdom

Lewis Krauskopf

Berkshire's bet a bright spot in gloomy year for Big Pharma stocks

18 Nov 2020

NEW YORK Berkshire Hathaway Inc's new bet on the U.S. pharmaceutical industry signals hope for shares of large drug companies, which have lagged a broad market rally amid concern about efforts to rein in prescription drug prices.

RPT-ANALYSIS-Berkshire's bet a bright spot in gloomy year for Big Pharma stocks

18 Nov 2020

NEW YORK, Nov 18 Berkshire Hathaway Inc's new bet on the U.S. pharmaceutical industry signals hope for shares of large drug companies, which have lagged a broad market rally amid concern about efforts to rein in prescription drug prices.

Analysis: Battered value bulls wary as vaccine news fuels cheap stock surge

13 Nov 2020

NEW YORK A long period of underperformance for value stocks has frustrated Mike Mullaney, whose firm's investing style is "all value, all the time."

Vaccine news catapults investors' economic-recovery bets

09 Nov 2020

SYDNEY/NEW YORK News of an effective vaccine against the novel coronavirus is fueling bets that a global economic recovery will buoy wide swaths of the market that have struggled under nearly nine months of the COVID-19 pandemic.

Investors celebrate Biden winning U.S. presidency

08 Nov 2020

NEW YORK Investors and financial executives took a big sigh of relief on Saturday after major networks declared Democrat Joe Biden winner of the U.S. presidential election, offering some certainty after days of conflicting reports about who might run the White House next term.

Investors likely relieved about networks calling U.S. presidential election for Biden

07 Nov 2020

NEW YORK, Nov 7 Markets will welcome the certainty after major networks declared Democrat Joe Biden winner of the U.S. presidential election on Saturday, offering some relief after days of the country getting conflicting reports about who might be in the White House next term.

Investors see silver-lining in U.S. election uncertainty

06 Nov 2020

LONDON/NEW YORK A definitive result on the next U.S. president may still be elusive, but two days after Election Day, investors are back in 'buy-everything' mode - counting on Republicans keeping control of the Senate and limiting regulatory change as well as on full central bank support.

World News